Figure 1 : Structures of the designed conjugates featured in this work.

From: Tropomyosin Receptor Kinase C Targeted Delivery of a Peptidomimetic Ligand-Photosensitizer Conjugate Induces Antitumor Immune Responses Following Photodynamic Therapy

Figure 1

(a) IYIY-I2-BODIPY is TrkC receptor targeted conjugate and (b) YIYI-I2-BODIPY is a scrambled control. Red represents the designed peptide-ligand portion, black for the linker and green for the parent iodinated BODIPY (I2-BODIPY).